Veracyte, Inc. (VCYT)
51.74
+3.54
(+7.34%)
USD |
NASDAQ |
Oct 27, 14:07
Veracyte Enterprise Value : 3.428B for Oct. 26, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 26, 2026 | 3.428B |
| October 23, 2026 | 3.407B |
| October 22, 2026 | 3.255B |
| October 21, 2026 | 3.269B |
| October 20, 2026 | 3.154B |
| October 19, 2026 | 3.075B |
| October 16, 2026 | 3.020B |
| October 15, 2026 | 3.122B |
| October 14, 2026 | 3.052B |
| October 13, 2026 | 3.019B |
| October 12, 2026 | 3.092B |
| October 09, 2026 | 3.190B |
| October 08, 2026 | 3.059B |
| October 07, 2026 | 3.023B |
| October 06, 2026 | 3.143B |
| October 05, 2026 | 3.386B |
| October 02, 2026 | 3.236B |
| October 01, 2026 | 3.106B |
| September 30, 2026 | 3.255B |
| September 29, 2026 | 3.258B |
| September 28, 2026 | 3.190B |
| September 25, 2026 | 3.206B |
| September 24, 2026 | 3.456B |
| September 23, 2026 | 3.076B |
| September 22, 2026 | 3.039B |
| Date | Value |
|---|---|
| September 21, 2026 | 2.892B |
| September 18, 2026 | 2.753B |
| September 17, 2026 | 2.815B |
| September 16, 2026 | 2.649B |
| September 15, 2026 | 2.781B |
| September 14, 2026 | 2.867B |
| September 11, 2026 | 2.839B |
| September 10, 2026 | 2.933B |
| September 09, 2026 | 3.080B |
| September 08, 2026 | 2.966B |
| September 04, 2026 | 2.973B |
| September 03, 2026 | 3.145B |
| September 02, 2026 | 3.162B |
| September 01, 2026 | 3.045B |
| August 31, 2026 | 3.026B |
| August 28, 2026 | 3.038B |
| August 27, 2026 | 3.191B |
| August 26, 2026 | 3.114B |
| August 25, 2026 | 3.094B |
| August 24, 2026 | 2.888B |
| August 21, 2026 | 2.955B |
| August 20, 2026 | 2.913B |
| August 19, 2026 | 2.945B |
| August 18, 2026 | 2.824B |
| August 17, 2026 | 2.937B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Teleflex, Inc. | 8.354B |
| West Pharmaceutical Services, Inc. | 27.67B |
| Globus Medical, Inc. | 10.50B |
| Illumina, Inc. | 42.29B |
| Inspire Medical Systems, Inc. | 1.761B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 25.49M |
| Revenue (Quarterly) | 150.32M |
| Total Expenses (Quarterly) | 124.83M |
| EPS Diluted (Quarterly) | 0.3106 |
| Gross Profit Margin (Quarterly) | 71.93% |
| Profit Margin (Quarterly) | 16.96% |
| Earnings Yield | 2.72% |
| Operating Earnings Yield | 2.31% |
| Normalized Earnings Yield | 2.493 |